Temenos AG
SIX:TEMN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Temenos AG
SIX:TEMN
|
CH |
|
Oric Pharmaceuticals Inc
F:4TZ
|
US |
|
B
|
Burberry Group PLC
XMUN:BB2
|
UK |
|
AECOM
NYSE:ACM
|
US |
|
Dr Martens PLC
LSE:DOCS
|
UK |
|
Tele2 AB
F:NCYD
|
SE |
|
Brigade Enterprises Ltd
NSE:BRIGADE
|
IN |
Wall St Price Targets
TEMN Price Targets Summary
Temenos AG
According to Wall Street analysts, the average 1-year price target for TEMN is 78.57 CHF with a low forecast of 56.56 CHF and a high forecast of 105 CHF.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TEMN's stock price target?
Price Target
78.57
CHF
According to Wall Street analysts, the average 1-year price target for TEMN is 78.57 CHF with a low forecast of 56.56 CHF and a high forecast of 105 CHF.
What is the Revenue forecast for Temenos AG?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 8 years is 7%.
What is the Gross Profit forecast for Temenos AG?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 8 years is 7%.
What is the Operating Income forecast for Temenos AG?
Projected CAGR
18%
Over the last 13 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 3 years is 18%.
What is the Pre-Tax Income forecast for Temenos AG?
Projected CAGR
16%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 19%. The projected CAGR for the next 3 years is 16%.
What is the Net Income forecast for Temenos AG?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Net Income has been 21%. The projected CAGR for the next 8 years is 9%.
